Published studies have indicated that HLA-DQA1 is a feasible biomarker that plays an important role in ESCC progression and diagnosis, as well as a potential target for the treatment of patients with ESCC [27]. The gene discussed is HLA-DQA1; the disease is esophageal squamous cell carcinoma.